Positron emission tomography in Parkinson’s disease: insights into impulsivity

References

• Antonini, A., Schwarz, J., Oertel, W.H., Beer, H.F., Madeja, U.D., & Leenders, K.L. (1994). [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson’s disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors. Neurology, 44, 1325–1329. doi:10.1212/WNL.44.7.1325
   PubMed Web of Science ®Google Scholar
• Antonini, A., Schwarz, J., Oertel, W.H., Pogarell, O., & Leenders, K.L. (1997). Long-term changes of striatal dopamine D2 receptors in patients with Parkinson’s disease: A study with positron emission tomography and [11C]raclopride. Mov Disord, 12, 33–38. doi:10.1002/mds.870120107
   PubMed Web of Science ®Google Scholar
• Baarendse, P.J., & Vanderschuren, L.J. (2012). Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats. Psychopharmacology (Berlin), 219, 313–326. doi:10.1007/s00213-011-2576-x
   PubMed Web of Science ®Google Scholar
• Bodi, N., Keri, S., Nagy, H., Moustafa, A., Myers, C.E., Daw, N., … Gluck, M.A. (2009). Reward-learning and the novelty-seeking personality: A between- and within-subjects study of the effects of dopamine agonists on young Parkinson’s patients. Brain, 132, 2385–2395. doi:10.1093/brain/awp094
   PubMed Web of Science ®Google Scholar
• Boileau, I., Guttman, M., Rusjan, P., Adams, J.R., Houle, S., Tong, J., … Kish, S.J. (2009). Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson’s disease. Brain, 132, 1366–1375. doi:10.1093/brain/awn337
   PubMed Web of Science ®Google Scholar
• Caine, S.B., & Koob, G.F. (1994). Effects of mesolimbic dopamine depletion on responding maintained by cocaine and food. J Exp Anal Behav, 61, 213–221. doi:10.1901/jeab.1994.61-213
   PubMed Web of Science ®Google Scholar
• Chaudhuri, K.R., Healy, D.G., & Schapira, A.H. National Institute for Clinical Excellence. (2006). Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol, 5, 235–245. doi:10.1016/S1474-4422(06)70373-8
   PubMed Web of Science ®Google Scholar
• Chernoloz, O., El Mansari, M., & Blier, P. (2009). Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain. Neuropsychopharmacology, 34, 651–661. doi:10.1038/npp.2008.114
   PubMed Web of Science ®Google Scholar
• Cilia, R., Ko, J.H., Cho, S.S., van Eimeren, T., Marotta, G., Pellecchia, G., … Strafella, A.P. (2010). Reduced dopamine transporter density in the ventral striatum of patients with Parkinson’s disease and pathological gambling. Neurobiol Dis, 39, 98–104. doi:10.1016/j.nbd.2010.03.013
   PubMed Web of Science ®Google Scholar
• Claassen, D.O., Kanoff, K., & Wylie, S.A. (2013). Dopamine agonists and impulse control disorders in Parkinson’s disease. US Neurol, 9, (1): 13–16. doi:10.17925/USN.2013.09.01.13
   Google Scholar
• Dalley, J.W., Fryer, T.D., Brichard, L., Robinson, E.S., Theobald, D.E., Laane, K., … Robbins, T.W. (2007). Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science, 315, 1267–1270. doi:10.1126/science.1137073
   PubMed Web of Science ®Google Scholar
• Dickson, D.W., Braak, H., Duda, J.E., Duyckaerts, C., Gasser, T., Halliday, G.M., … Litvan, I. (2009). Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria. Lancet Neurol, 8, 1150–1157. doi:10.1016/S1474-4422(09)7023-8
   PubMed Web of Science ®Google Scholar
• Dreher, J.C., Kohn, P., Kolachana, B., Weinberger, D.R., & Berman, K.F. (2009). Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci USA, 106, 617–622. doi:10.1073/pnas.0805517106
   PubMed Web of Science ®Google Scholar
• Egerton, A., Hirani, E., Ahmad, R., Turton, D.R., Brickute, D., Rosso, L., … Grasby, P.M. (2010). Further evaluation of the carbon11-labeled D(2/3) agonist PET radiotracer PHNO: Reproducibility in tracer characteristics and characterization of extrastriatal binding. Synapse, 64, 301–312. doi:10.1002/syn.20718
   PubMed Web of Science ®Google Scholar
• Evans, A.H., Katzenschlager, R., Paviour, D., O’sullivan, J.D., Appel, S., Lawrence, A.D., & Lees, A.J.. (2004). Punding in Parkinson’s disease: Its relation to the dopamine dysregulation syndrome. Mov Disord, 19, 397–405. doi:10.1002/mds.20045
   PubMed Web of Science ®Google Scholar
• Evans, A.H., Lawrence, A.D., Potts, J., MacGregor, L., Katzenschlager, R., Shaw, K., … Lees, A.J. (2006). Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson’s disease. J Neurol Neurosurg Psychiatry, 77, 317–321. doi:10.1136/jnnp.2005.065417
   PubMed Web of Science ®Google Scholar
• Evans, A.H., Pavese, N., Lawrence, A.D., Tai, Y.F., Appel, S., Doder, M., … Piccini, P. (2006). Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol, 59, 852–858. doi:10.1002/ana.20822
   PubMed Web of Science ®Google Scholar
• Everitt, B.J., & Robbins, T.W. (2005). Neural systems of reinforcement for drug addiction: From actions to habits to compulsion. Nat Neurosci, 8, 1481–1489. doi:10.1038/nn1579
   PubMed Web of Science ®Google Scholar
• Falardeau, P., Bedard, P.J., & Di Paolo, T. (1988). Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys. Neurosci Lett, 86, 225–229. doi:10.1016/0304-3940(88)90575-7
   PubMed Web of Science ®Google Scholar
• Farde, L., Suhara, T., Nyberg, S., Karlsson, P., Nakashima, Y., Hietala, J., & Halldin, C. (1997). A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology (Berlin), 133, 396–404. doi:10.1007/s002130050420
   PubMed Web of Science ®Google Scholar
• Frank, M.J., Seeberger, L.C., & O’reilly, R.C. (2004). By carrot or by stick: Cognitive reinforcement learning in parkinsonism. Science, 306, 1940–1943. doi:10.1126/science.1102941
   PubMed Web of Science ®Google Scholar
• Garcia-Ruiz, P.J., Martinez Castrillo, J.C., Alonso-Canovas, A., Herranz Barcenas, A., Vela, L., Sanchez Alonso, P., … Mahillo Fernandez, I. (2014). Impulse control disorder in patients with Parkinson’s disease under dopamine agonist therapy: A multicentre study. J Neurol Neurosurg Psychiatry, 85, 840–844. doi:10.1136/jnnp-2013-306787
   PubMed Web of Science ®Google Scholar
• Gibb, W.R., & Lees, A.J. (1991). Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson’s disease. J Neurol Neurosurg Psychiatry, 54, 388–396. doi:10.1136/jnnp.54.5.388
   PubMed Web of Science ®Google Scholar
• Gleichgerrcht, E., Ibanez, A., Roca, M., Torralva, T., & Manes, F. (2010). Decision-making cognition in neurodegenerative diseases. Nat Rev Neurol, 6, 611–623. doi:10.1038/nrneurol.2010.148
   PubMed Web of Science ®Google Scholar
• Guttman, M., Stewart, D., Hussey, D., Wilson, A., Houle, S., & Kish, S. (2001). Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD. Neurology, 56, 1559–1564. doi:10.1212/WNL.56.11.1559
   PubMed Web of Science ®Google Scholar
• Haber, S.N., & Behrens, T.E. (2014). The neural network underlying incentive-based learning: Implications for interpreting circuit disruptions in psychiatric disorders. Neuron, 83, 1019–1039. doi:10.1016/j.neuron.2014.08.031
   PubMed Web of Science ®Google Scholar
• Haber, S.N., & Knutson, B. (2010). The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology, 35, 4–26. doi:10.1038/npp.2009.129
   PubMed Web of Science ®Google Scholar
• Hall, H., Ogren, S.O., Kohler, C., & Magnusson, O. (1989). Animal pharmacology of raclopride, a selective dopamine D2 antagonist. Psychopharmacol Ser, 7, 123–130. doi:10.1007/978-3-642-74430-3_13
   PubMedGoogle Scholar
• Hirvonen, J., Aalto, S., Lumme, V., Nagren, K., Kajander, J., Vilkman, H., … Hietala, J. (2003). Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride. Nucl Med Commun, 24, 1207–1214. doi:10.1097/01.mnm.0000104642.79626.e8
   PubMed Web of Science ®Google Scholar
• Itokawa, M., Toru, M., Ito, K., Tsuga, H., Kameyama, K., Haga, T., … Hamaguchi, H. (1996). Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells. Mol Pharmacol, 49, 560–566. Retrieved from http://molpharm.aspetjournals.org/content/49/3/560.short
   PubMed Web of Science ®Google Scholar
• Kaasinen, V., Aalto, S., NAgren, K., Hietala, J., Sonninen, P., & Rinne, J.O. (2003). Extrastriatal dopamine D(2) receptors in Parkinson’s disease: a longitudinal study. J Neural Transm (Vienna), 110, 591–601. doi:10.1007/s00702-003-0816-x
   PubMed Web of Science ®Google Scholar
• Kaasinen, V., Nagren, K., Hietala, J., Oikonen, V., Vilkman, H., Farde, L., … Rinne, J.O. (2000). Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson’s disease. Neurology, 54, 1482–1487. doi:10.1212/WNL.54.7.1482
   PubMed Web of Science ®Google Scholar
• Kalia, L.V., & Lang, A.E. (2015). Parkinson’s disease. Lancet, 386, 896–912. doi:10.1016/S0140-6736(14)61393-3
   PubMed Web of Science ®Google Scholar
• Kim, K.M., Valenzano, K.J., Robinson, S.R., Yao, W.D., Barak, L.S., & Caron, M.G. (2001). Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins. J Biol Chem, 276, 37409–37414. doi:10.1074/jbc.M106728200
   PubMed Web of Science ®Google Scholar
• Kish, S.J., Shannak, K., & Hornykiewicz, O. (1988). Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease. Pathophysiologic and clinical implications. N Engl J Med, 318, 876–880. doi:10.1056/NEJM198804073181402
   PubMed Web of Science ®Google Scholar
• Ko, J.H., Antonelli, F., Monchi, O., Ray, N., Rusjan, P., Houle, S., … Strafella, A.P. (2013). Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson’s disease. Hum Brain Mapp, 34, 1591–1604. doi:10.1002/hbm.22006
   PubMed Web of Science ®Google Scholar
• Lindner, M.D., Cain, C.K., Plone, M.A., Frydel, B.R., Blaney, T.J., Emerich, D.F., … Hoane, M.R. (1999). Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats. Behav Brain Res, 102, 1–16. doi:10.1016/S0166-4328(98)00160-0
   PubMed Web of Science ®Google Scholar
• Menza, M.A., Golbe, L.I., Cody, R.A., & Forman, N.E. (1993). Dopamine-related personality traits in Parkinson’s disease. Neurology, 43, 505–508. doi:10.1212/WNL.43.3_Part_1.505
   PubMed Web of Science ®Google Scholar
• Mukherjee, J., Yang, Z.Y., Brown, T., Lew, R., Wernick, M., Ouyang, X., … Cooper, M. (1999). Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride. Nucl Med Biol, 26, 519–527. doi:10.1016/S0969-8051(99)00012-8
   PubMed Web of Science ®Google Scholar
• Nader, M.A., Morgan, D., Gage, H.D., Nader, S.H., Calhoun, T.L., Buchheimer, N., … Mach, R.H. (2006). PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci, 9, 1050–1056. doi:10.1038/nn1737
   PubMed Web of Science ®Google Scholar
• Narendran, R., Frankle, W.G., Mason, N.S., Rabiner, E.A., Gunn, R.N., Searle, G.E., … Laruelle, M. (2009). Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride. Synapse, 63, 447–461. doi:10.1002/syn.20628
   PubMed Web of Science ®Google Scholar
• O’Doherty, J., Dayan, P., Schultz, J., Deichmann, R., Friston, K., & Dolan, R.J. (2004). Dissociable roles of ventral and dorsal striatum in instrumental conditioning. Science, 304, 452–454. doi:10.1126/science.1094285
   PubMed Web of Science ®Google Scholar
• O’Sullivan, S.S., Wu, K., Politis, M., Lawrence, A.D., Evans, A.H., Bose, S.K., … Piccini, P. (2011). Cue-induced striatal dopamine release in Parkinson’s disease-associated impulsive-compulsive behaviours. Brain, 134, 969–978. doi:10.1093/brain/awr003
   PubMed Web of Science ®Google Scholar
• Olsson, H., Halldin, C., Swahn, C.G., & Farde, L. (1999). Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. J Cereb Blood Flow Metab, 19, 1164–1173. doi:10.1097/00004647-199910000-00013
   PubMed Web of Science ®Google Scholar
• Parkinson Study Group. (2002). Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA, 287, 1653–1661. doi:10.1001/jama.287.13.1653
   PubMed Web of Science ®Google Scholar
• Pattij, T., Janssen, M.C., Vanderschuren, L.J., Schoffelmeer, A.N., & van Gaalen, M.M. (2007). Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control. Psychopharmacology (Berl), 191, 587–598. doi:10.1007/s00213-006-0533-x
   PubMed Web of Science ®Google Scholar
• Payer, D.E., Guttman, M., Kish, S.J., Tong, J., Strafella, A., Zack, M., … Boileau, I. (2015). [(1)(1)C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson’s disease with impulse control disorders. Mov Disord, 30, 160–166. doi:10.1002/mds.26135
   PubMedGoogle Scholar
• Perlmutter, J.S., & Norris, S.A. (2014). Neuroimaging biomarkers for Parkinson disease: Facts and fantasy. Ann Neurol, 76, 769–783. doi:10.1002/ana.24291
   PubMedGoogle Scholar
• Pettit, H.O., Ettenberg, A., Bloom, F.E., & Koob, G.F. (1984). Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl), 84, 167–173. doi:10.1007/BF00427441
   PubMed Web of Science ®Google Scholar
• Ray, N.J., Miyasaki, J.M., Zurowski, M., Ko, J.H., Cho, S.S., Pellecchia, G., … Strafella, A.P. (2012). Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson’s patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study. Neurobiol Dis, 48, 519–525. doi:10.1016/j.nbd.2012.06.021
   PubMed Web of Science ®Google Scholar
• Remy, P., Doder, M., Lees, A., Turjanski, N., & Brooks, D. (2005). Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain, 128, 1314–1322. doi:10.1093/brain/awh445
   PubMed Web of Science ®Google Scholar
• Rinne, J.O., Laihinen, A., Rinne, U.K., Nagren, K., Bergman, J., & Ruotsalainen, U. (1993). PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson’s disease. Mov Disord, 8, 134–138. doi:10.1002/mds.870080203
   PubMed Web of Science ®Google Scholar
• Rinne, J.O., Laihinen, A., Ruottinen, H., Ruotsalainen, U., Nagren, K., Lehikoinen, P., … Rinne, U.K. (1995). Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson’s disease: a PET study with [11C]raclopride. J Neurol Sci, 132, 156–161. doi:10.1016/0022-510X(95)00137-Q
   PubMed Web of Science ®Google Scholar
• Scherfler, C., Schwarz, J., Antonini, A., Grosset, D., Valldeoriola, F., Marek, K., … Poewe, W. (2007). Role of DAT-SPECT in the diagnostic work up of parkinsonism. Mov Disord, 22, 1229–1238. doi:10.1002/mds.21505
   PubMed Web of Science ®Google Scholar
• Smith, K.M., Xie, S.X., & Weintraub, D. (2016). Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry, 87, 864–870. doi:10.1136/jnnp-2015-311827
   PubMed Web of Science ®Google Scholar
• Steeves, T.D., Miyasaki, J., Zurowski, M., Lang, A.E., Pellecchia, G., Van Eimeren, T., … Strafella, A.P. (2009). Increased striatal dopamine release in parkinsonian patients with pathological gambling: A [11C] raclopride PET study. Brain, 132, 1376–1385. doi:10.1093/brain/awp054
   PubMed Web of Science ®Google Scholar
• Thanos, P.K., Michaelides, M., Umegaki, H., & Volkow, N.D. (2008). D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse, 62, 481–486. doi:10.1002/syn.20523
   PubMed Web of Science ®Google Scholar
• Thanos, P.K., Volkow, N.D., Freimuth, P., Umegaki, H., Ikari, H., Roth, G., … Hitzemann, R. (2001). Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem, 78, 1094–1103. doi:10.1046/j.1471-4159.2001.00492.x
   PubMed Web of Science ®Google Scholar
• Trifilieff, P., Feng, B., Urizar, E., Winiger, V., Ward, R.D., Taylor, K.M., … Javitch, J.A. (2013). Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation. Mol Psychiatry, 18, 1025–1033. doi:10.1038/mp.2013.57
   PubMed Web of Science ®Google Scholar
• Trifilieff, P., & Martinez, D. (2014). Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity. Neuropharmacology, 76 Pt B, 498–509. doi:10.1016/j.neuropharm.2013.06.031
   PubMed Web of Science ®Google Scholar
• Troiano, A.R., de la Fuente-Fernandez, R., Sossi, V., Schulzer, M., Mak, E., Ruth, T.J., … Stoessl, A.J. (2009). PET demonstrates reduced dopamine transporter expression in PD with dyskinesias. Neurology, 72, 1211–1216. doi:10.1212/01.wnl.0000338631.73211.56
   PubMed Web of Science ®Google Scholar
• Vaillancourt, D.E., Schonfeld, D., Kwak, Y., Bohnen, N.I., & Seidler, R. (2013). Dopamine overdose hypothesis: Evidence and clinical implications. Mov Disord, 28, 1920–1929. doi:10.1002/mds.25687
   PubMed Web of Science ®Google Scholar
• Vanderschuren, L.J., Di Ciano, P., & Everitt, B.J. (2005). Involvement of the dorsal striatum in cue-controlled cocaine seeking. J Neurosci, 25, 8665–8670. doi:10.1523/JNEUROSCI.0925-05.2005
   PubMed Web of Science ®Google Scholar
• Voon, V., Potenza, M.N., & Thomsen, T. (2007). Medication-related impulse control and repetitive behaviors in Parkinson’s disease. Curr Opin Neurol, 20, 484–492. doi:10.1097/WCO.0b013e32826fbc8f
   PubMed Web of Science ®Google Scholar
• Voon, V., Rizos, A., Chakravartty, R., Mulholland, N., Robinson, S., Howell, N.A., … Ray Chaudhuri, K. (2014). Impulse control disorders in Parkinson’s disease: Decreased striatal dopamine transporter levels. J Neurol Neurosurg Psychiatry, 85, 148–152. doi:10.1136/jnnp-2013-305395
   PubMed Web of Science ®Google Scholar
• Vriend, C., Nordbeck, A.H., Booij, J., van der Werf, Y.D., Pattij, T., Voorn, P., … van den Heuvel, O.A. (2014). Reduced dopamine transporter binding predates impulse control disorders in Parkinson’s disease. Mov Disord, 29, 904–911. doi:10.1002/mds.25886
   PubMedGoogle Scholar
• Weintraub, D., David, A.S., Evans, A.H., Grant, J.E., & Stacy, M. (2015). Clinical spectrum of impulse control disorders in Parkinson’s disease. Mov Disord, 30, 121–127. doi:10.1002/mds.26016
   PubMed Web of Science ®Google Scholar
• Yin, H.H., Knowlton, B.J., & Balleine, B.W. (2004). Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur J Neurosci, 19, 181–189. doi:10.1111/j.1460-9568.2004.03095.x
   PubMed Web of Science ®Google Scholar